Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
209 studies found for:    pediatric AND glioma
Show Display Options
Rank Status Study
1 Completed Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas
Condition: Pediatric High Risk Gliomas
Intervention: Drug: Combination of two marketed drugs (irinotecan and cisplatin)
2 Terminated An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma
Conditions: Brain Neoplasm;   Glioma
Intervention: Drug: IL13-PE38QQR
3 Recruiting A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Conditions: Pilomyxoid Astrocytoma;   Pilocytic Astrocytoma;   Glioma, Astrocytic;   Optic Nerve Glioma;   Pleomorphic Xanthoastrocytoma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Gliosarcoma;   Diffuse Intrinsic Pontine Glioma;   DIPG;   Low-grade Glioma;   Brainstem Glioma
Interventions: Drug: Mebendazole;   Drug: Vincristine;   Drug: Carboplatin;   Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
4 Recruiting HUMC 1612: Optune NovoTTF-200A System
Condition: High Grade Glioma
Interventions: Device: Optune NovoTTF-200A System;   Drug: Bevacizumab;   Drug: Temozolomide
5 Recruiting A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction With Poly-ICLC in Pediatric Gliomas
Conditions: Newly Diagnosed Pediatric Pontine Glioma;   Newly Diagnosed Pediatric High Grade Glioma;   Recurrent Pediatric High Grade Glioma;   Recurrent Pediatric Low Grade Glioma
Interventions: Biological: HLA-A2 restricted glioma antigen peptides vaccine;   Biological: Poly-ICLC
6 Completed Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma
Condition: Diffuse Intrinsic Brainstem Gliomas
Interventions: Radiation: Radiotherapy;   Biological: Nimotuzumab
7 Terminated
Has Results
Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma
Condition: Pontine Glioma
Intervention: Drug: Vismodegib
8 Withdrawn Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma
Condition: Recurrent Malignant Glioma
Intervention: Drug: IL13-PE38QQR
9 Recruiting Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
Condition: Glioblastoma Multiforme
Interventions: Drug: ABT-414;   Drug: Lomustine;   Drug: Temozolomide
10 Terminated Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: O6-benzylguanine;   Drug: polifeprosan 20 with carmustine implant;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
11 Recruiting Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children
Condition: Pediatric Brain Stem Glioma
Interventions: Radiation: Hypofractionated Arm (1);   Radiation: Hypofractionated Arm (2);   Radiation: Conventional Arm (3)
12 Completed Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Conditions: Brain Stem Neoplasms, Primary;   Neoplasms, Brain Stem
Interventions: Drug: Carboplatin;   Drug: Thalomid;   Procedure: External Beam Radiation Therapy
13 Recruiting Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
Conditions: Diffuse Intrinsic Pontine Glioma;   High-grade Glioma
Interventions: Drug: Crizotinib;   Drug: Dasatinib
14 Completed Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma
Condition: Recurrent Diffuse Pontine Gliomas
Intervention: Biological: nimotuzumab (anti EGFR humanized monoclonal antibody)
15 Recruiting A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
Conditions: Glioblastoma;   Diffuse Intrinsic Pontine Glioma
Intervention: Drug: DSP-7888
16 Active, not recruiting PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Conditions: Pediatric Recurrent Progressive Low-grade Gliomas;   Pediatric Progressive Low-grade Gliomas
Intervention: Drug: Everolimus
17 Completed Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: vandetanib
18 Terminated Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs
Conditions: Gliomas;   Medulloblastoma;   Neuroectodermal Tumors, Primitive
Interventions: Biological: Vaccine (autologous dendritic cells);   Drug: Decitabine and Hiltonol
19 Recruiting A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas
Condition: Brain Tumors
Intervention: Drug: Poly ICLC
20 Completed
Has Results
Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma
Condition: Untreated Childhood Brain Stem Glioma
Interventions: Radiation: radiation therapy;   Drug: tipifarnib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.